Search

Your search keyword '"Kitano, M."' showing total 1,867 results

Search Constraints

Start Over You searched for: Author "Kitano, M." Remove constraint Author: "Kitano, M."
1,867 results on '"Kitano, M."'

Search Results

1. POS1251 ORAL HEALTH-RELATED QUALITY OF LIFE IN SJÖGREN’S SYNDROME PATIENTS WITH UNSTIMULATED WHOLE SALIVARY FLOWS ≥0.1 ML/MIN FOR WHOM NO THERAPEUTIC APPROACHES ARE PROVIDED IN THE EULAR RECOMMENDATIONS

3. Helical mode conversion using conical reflector

4. Nonlinear behavior of geometric phases induced by photon pairs

5. Direct observation of geometric phases using a three-pinhole interferometer

6. Observation of geometric phases in quantum erasers

7. An invisible medium for circularly polarized electromagnetic waves

8. Observation of Brewster's effect for transverse-electric electromagnetic waves in metamaterials: Experiment and theory

9. Simulation of Slow Light with Electronics Circuits

10. Negative Group Delay and Superluminal Propagation: An Electronic Circuit Approach

11. Generation of photon pairs using polarization-dependent two-photon absorption

12. Demonstration of negative group delays in a simple electronic circuit

13. Absorption-free optical control of spin systems:the quantum Zeno effect in optical pumping

15. Geometry of One-Dimensional Wave Propagation

16. 93P Outcomes by disease status in patients with advanced biliary tract cancer treated with durvalumab or placebo plus gemcitabine and cisplatin in the phase III TOPAZ-1 study

17. 78P Updated overall survival (OS) from the phase III TOPAZ-1 study of durvalumab (D) or placebo (PBO) plus gemcitabine and cisplatin (+ GC) in patients (pts) with advanced biliary tract cancer (BTC)

19. 56P Updated overall survival (OS) from the phase III TOPAZ-1 study of durvalumab (D) or placebo (PBO) plus gemcitabine and cisplatin (+ GC) in patients (pts) with advanced biliary tract cancer (BTC)

20. Lobar analysis of collapsibility indices to assess functional lung volumes in COPD patients

21. PD-8 Outcomes by disease status in patients with advanced biliary tract cancer treated with durvalumab or placebo plus gemcitabine and cisplatin in the phase 3 TOPAZ-1 study

26. Corrigendum to “78P Updated overall survival (OS) from the phase III TOPAZ-1 study of durvalumab (D) or placebo (PBO) plus gemcitabine and cisplatin (+ GC) in patients (pts) with advanced biliary tract cancer (BTC)”: [Annals of Oncology 33 (2022) S1462-S1463]

36. Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium

39. OC.01.1 EUS-FNB WITH VERSUS WITHOUT ROSE: INTERIM ANALYSIS OF AN INTERNATIONAL RANDOMIZED NON-INFERIORITY STUDY

40. Simulation of slow light with electronic circuits

41. Dynamic imaging of pancreatic diseases by contrast enhanced coded phase inversion harmonic ultrasonography

47. EUS-FNB WITH VERSUS WITHOUT ROSE: INTERIM ANALYSIS OF AN INTERNATIONAL RANDOMIZED NON-INFERIORITY STUDY

50. Photocatalysis

Catalog

Books, media, physical & digital resources